Last Update Time:
17-Mar-2025 16:00:00
ISIN:
INE258B01022
Sector:
Healthcare
Symbol:
FDC
FDC Limited
₹400.00
₹9.10
(2.33%)
▲
Prev. Close
₹390.90
Open
₹390.90
Close
₹400.15
Range
₹380.00 - ₹420.00
High
₹403.45
Low
₹390.00
Ind. Close
₹0.00
VWAP
₹399.93
The current stock price of FDC Limited is ₹400.00, with a target price range between ₹380.00 and ₹420.00. The stock has experienced a price change of ₹9.10 (2.33%), reflecting recent market volatility.
Today's opening price was ₹390.90, while the previous close stood at ₹390.90.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
FDC Limited Price Chart
FDC Limited Pre Open Market Overview: 17-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 390.9
- Previous Close Price: 390.9
- Change: 0.00%
- Total Traded Volume: 195
- Total Buy Quantity: 5,987
- Total Sell Quantity: 7,189
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 388.05 | 102.00 | 0.00 |
| 388.90 | 3.00 | 0.00 |
| 390.00 | 10.00 | 0.00 |
| 390.90 | 1.00 | 0.00 |
| 391.00 | 123.00 | 0.00 |
| 391.40 | 0.00 | 17.00 |
| 392.25 | 0.00 | 17.00 |
| 393.10 | 0.00 | 17.00 |
| 393.95 | 0.00 | 17.00 |
| 394.25 | 0.00 | 26.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 5987
Total Sell Quantity: 7189
Shareholding Patterns of FDC Limited
Key Trade Statistics of FDC Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 1.11 |
| Traded Value (₹ Cr.) | 4.42 |
| Total Market Cap (₹ Cr.) | 6,512.40 |
| Free Float Market Cap (₹ Cr.) | 1,961.77 |
| Impact cost | 0.1 |
| Quantity Traded | 110,631.00 |
| Deliverable Quantity | 66,191.00 |
| % of Quantity to Traded | 59.83 |
| Security VaR | 12.78 |
| Index VaR | N/A |
| VaR Margin | 12.78 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 16.28 |
| Face Value | 1 |
Key Price Statistics of FDC Limited
The 52-week high for FDC Limited was ₹658.85, recorded on 12-Sep-2024. On the other hand, the 52-week low stands at ₹366.25, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹469.05, and the lower band is ₹312.75. The price band is 20%.
The stock's daily volatility stands at 2.00, while the annualized volatility is 38.21. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (12-Sep-2024) | 658.85 |
| 52 Week Low (03-Mar-2025) | 366.25 |
| Upper Band | 469.05 |
| Lower Band | 312.75 |
| Price Band (%) | 20 |
| Daily Volatility | 2.00 |
| Annualised Volatility | 38.21 |
| Tick Size | 0.05 |
Key Securities Statistics of FDC Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 07-Aug-1997 |
| Adjusted P/E | 23.19 |
| Symbol P/E | 23.19 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of FDC Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of FDC Limited
| Subject | Date |
|---|---|
| General Updates | 19-Feb-2025 |
| Integrated Filing- Financial | 12-Feb-2025 |
| Press Release | 12-Feb-2025 |
| Financial Result Updates | 12-Feb-2025 |
| Outcome of Board Meeting | 12-Feb-2025 |
| Board Meeting Intimation | 07-Feb-2025 |
| Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 31-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 10-Jan-2025 |
Corporate Actions of FDC Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Interim Dividend - Rs 5 Per Share | 22-Nov-2024 |
| 1 | Annual General Meeting | 19-Sep-2024 |
| 1 | Annual General Meeting | 20-Sep-2023 |
| 1 | Buy Back | 25-Aug-2023 |
| 1 | Annual General Meeting | 13-Sep-2022 |
| 1 | Buy Back | 17-Feb-2022 |
| 1 | Annual General Meeting | 20-Sep-2021 |
| 1 | Annual General Meeting | 22-Sep-2020 |
| 1 | Buyback | 20-Aug-2020 |
| 1 | Interim Dividend - Rs 0.80 Per Share | 19-Mar-2020 |
| 1 | Annual General Meeting | 19-Sep-2019 |
| 1 | Buyback | 06-Jun-2019 |
| 1 | Annual General Meeting | 30-Aug-2018 |
| 1 | Buyback | 26-Feb-2018 |
| 1 | Annual General Meeting/Dividend - Rs 2.25 Per Share | 08-Aug-2017 |
| 1 | Annual General Meeting | 06-Sep-2016 |
| 1 | Interim Dividend - Rs 2.25/- Per Share | 17-Mar-2016 |
| 1 | Annual General Meeting/ Dividend - Rs 2.25/- Per Share | 23-Sep-2015 |
| 1 | Annual General Meeting/Dividend Rs 2.25/- Per Share | 28-Jul-2014 |
| 1 | Annual General Meeting / Dividend - Rs 2.25/- Per Share | 20-Aug-2013 |
Board Meetings of FDC Limited
Financial Results of FDC Limited
Company Directory of FDC Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.fdcindia.com | Head Office/ Corporate Office | 142-148, S.V. Road Jogeshwari (W) | MUMBAI |
| www.fdcindia.com | Registered Office | B-8, M.I.D.C. Industrial Estate 142-48, S V Road, Jogeshwari West-400102 | WALUJ |
| www.fdcindia.com | Transfer Agent | M/s. Sharex Dynamic (India) Pvt. Ltd Unit-I, Luthra Industrial Premises, Andheri Kurla Road, Safed Pool, Andheri(E), | MUMBAI |
Insider Trading of FDC Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Meera Ramdas Chandavarkar | 0 | Sell |
| 7(2) | Nomita Ramdas Chandavarkar | 0 | Buy |
| 7(2) | Melarkode Ganesan Parameswaran | 912383 | Buy |
| 7(2) | Mohan Anand Chandavarkar Trust | 90979650 | Sell |
| 7(2) | Meera Ramdas Chandavarkar | 163575450 | Sell |
| 7(2) | Aditi C Bhanot | 5739750 | Sell |
| 7(2) | Nomita Ramdas Chandavarkar | 27183150 | Sell |
| 7(2) | Nandan Mohan Chandavarkar | 26048700 | Sell |
| 7(2) | Ameya Ashok Chandavarkar | 51279750 | Sell |
| 7(2) | SANDHYA MOHAN CHANDAVARKAR TRUST | 92583900 | Sell |
| 7(2) | VIRGO ADVISORS PRIVATE LIMITED | 51449400 | Sell |
| 7(2) | LEO ADVISORS PRIVATE LIMITED | 77173650 | Sell |
| 7(2) | Meera Ramdas Chandavarkar | 203242900 | Sell |
| 7(2) | Aditi C Bhanot | 7131600 | Sell |
| 7(2) | VIRGO ADVISORS PVT LTD | 63926100 | Sell |
| 7(2) | LEO ADVISORS PVT LTD | 95888450 | Sell |
| 7(2) | Ameya Ashok Chandavarkar | 63715050 | Sell |
| 7(2) | Sandhya Mohan Chandavarkar Trust | 115035900 | Sell |
| 7(2) | Mohan Anand Chandavarkar Trust | 113042300 | Sell |
| 7(2) | Nandan Mohan Chandavarkar | 32365550 | Sell |
Annual Reports of FDC Limited
Investor Complaints of FDC Limited
Event Calendar of FDC Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2010. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2010. |
| Results / Buyback | The Company had informed the Exchange that a meeting of the Board of Directors of the Company was scheduled to be held on January 27, 2011, to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2010. The Company has now informed the Exchange that the board will inter-alia also consider the Buy back of equity shares of the Company. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2011. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2011. |
| Results/Dividend/Buyback | The Company had informed the Exchange regarding a Board meeting to be held on May 26, 2012 to interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2012. The Company has now informed the Exchange that at the Board Meeting scheduled to be held on May 26, 2012 the Board will inter-alia also consider the Buy back of equity shares of the Company. (Purpose Revised) |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2012. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2013. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2013. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2013. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2013. |
| Results | To inter alia consider and approve the unaudited financial results of the Company for the quarter and nine months ending December 31, 2013. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2014. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2014. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2014. |
| Amalgamation/Merger | To discuss the amalgamation of Soven Trading & Investment Company Private Limited, Sudipta Trading & Investment Company Private Limited, Transgene Trading & Investment Company Private Limited and Anand Synthochem Limited (collectively referred to as the "Transferor Companies") in FDC Limited ("Transferee Company" or "Company") and their respective shareholders. Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the equity shares of the Company will remain closed from August 28, 2014 to September 08, 2014 (both days inclusive). Accordingly, Directors /Designated employees shall not trade in the equity shares of the Company during the above said period. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter and six months ended September 30, 2014. |
| Results | To inter-alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2014. |
| Others | inter alia to consider and approve the notice of postal ballot and court convened meeting with respect to the proposed Amalgamation of Soven Trading and Investment Company Private Limited, Sudipta Trading and investment Company Private Limited, Transgene Trading and Investment Company Private Limited and Anand Synthochem Limited with Company. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2015. Also, please note the Board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2015. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2015. |
| Results | To inter alia, consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2015. |
| Results | to inter alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2015. |
| Dividend | To inter alia, consider and declare the payment of Interim Dividend to the shareholders of the Company for the Financial Year 2015-16. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2016. Further the Board will also interalia, consider the recommendation of dividend, if any, for the year ended March 31, 2016. |
| Results | To interalia, consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016. |
| Results | To interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016. Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from November 02, 2016 to November 11, 2016 (both days inclusive). |
| Results | To interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016. |
| Results/Dividend | To interalia, consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017. Also, please note the Board will also interalia, consider the recommendation of dividend, if any, for the year ended March 31, 2017. |
| Results | to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. |
| Results/Others | to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017. |
| Results | To interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. |
| Financial Results/Dividend | To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2018. Further the Board will also interalia, consider the recommendation of dividend, if any, for the year ended 31st March, 2018 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended June 30, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results/Buyback | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 24, 2019 to inter alia, consider and approve the Audited Financial Results of the Company for the Quarter and Financial year ended March 31, 2019. The company has now informed the exchange that at the said meeting scheduled to be held on May 24, 2019, the Board of Directors shall also consider the proposal for buyback of fully paid up equity shares of the Company through Tender Offer route. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Dividend | Board of Directors of FDC Limited (the "Company") may consider Interim Dividend for the Financial Year 2019-2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Dividend/Other business matters | To consider dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
| Buyback | To consider buyback for equity shares |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Buyback | Update on board meeting - This is in continuation to our Letter dated August 01, 2023, intimating the meeting of the Board of Directors of the Company which is scheduled to be held on Wednesday, August 09, 2023, to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended June 30, 2023.In terms of Regulation 29(1)(b) of the SEBI Listing Regulations, we hereby inform that at the said meeting, the Board of Directors will also consider the proposal for buyback of fully paid up equity shares of the Company in accordance with the relevant provision of the Companies Act, 2013 and the SEBI (Buyback of Securities) Regulations, 2018 and amendments therein, and other applicable laws. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the Unaudited financial results for the Quarter ended June 30, 2024, and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter and half year ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter and nine months ended December 31, 2024 and other business matters |
Share Transfers of FDC Limited
Voting Results of FDC Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 26-SEP-2024 | AGM | To consider and adopt the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2024 together with the Reports of the Board of Directors and Auditors thereon. |
| 26-SEP-2024 | AGM | Approval of Payment of Commission to Non- Executive Directors of the Company for each financial year commencing from April 01, 2024. |
| 26-SEP-2024 | AGM | Appointment of Dr. Charuta Nityanath Mandke (DIN: 08953268) as Non Executive Independent Director of the Company. |
| 26-SEP-2024 | AGM | Re-appointment of Mr. Ameya A. Chandavarkar (DIN: 00043238) as a CEO-International Business & Executive Director of the Company. |
| 26-SEP-2024 | AGM | Ratification of the remuneration of the Cost Auditors for the Financial Year 2024￢ﾀﾓ25. |
| 26-SEP-2024 | AGM | To re-appoint Ms. Nomita R. Chandavarkar (DIN: 00042332) as a Director, who retires by rotation and being eligible, offered herself for re-appointment. |
| 26-SEP-2024 | AGM | To consider and adopt the Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2024 along with Report of the Auditors thereon. |
| 20-JUL-2024 | Postal Ballot | RE-APPOINTMENT OF DR. MAHESH BIJLANI (DIN: 08447258) AS AN NON- EXECUTIVE & INDEPENDENTnDIRECTOR OF THE COMPANY FOR A PERIOD OF 5 YEARS WITH EFFECT FROM MAY 10, 2024 |
| 27-SEP-2023 | AGM | Adoption of the Audited Standalone Financial Statements of the Company for the Financial year ended March 31, 2023 together with the Reports of the Board of Directors and Auditors thereon |
| 27-SEP-2023 | AGM | Re-appointment of Ms. Nomita R. Chandavarkar (DIN: 00042332) as a Non-Executive Non-Independent Director of the Company for a term of 5 (Five) consecutive years with effect from June 02, 2024 to June 01, 2029 and shall be liable to retire by rotation. |
| 27-SEP-2023 | AGM | Re-appointment of Mr. Mohan A. Chandavarkar (DIN: 00043344) as a Managing Director of the Company for a further period of 5 (five) years with effect from April 01, 2024 to March 31, 2029, not liable to retire by rotation. |
| 27-SEP-2023 | AGM | Re-appointment of Mr. Nandan M. Chandavarkar (DIN: 00043511) as a Joint Managing Director of the Company for a further period of 5 (five) years with effect from March 01, 2024 to February 28, 2029, not liable to retire by rotation. |
| 27-SEP-2023 | AGM | Ratification of the Remuneration of Cost Auditor for the Financial Year 2023-24. |
| 27-SEP-2023 | AGM | Re-appointment of Mr. Ashok A. Chandavarkar (DIN: 00042719) as a Director, who retires by rotation and being eligible, offered himself for Re-appointment. |
| 27-SEP-2023 | AGM | Adoption of the Audited Consolidated Financial Statements of the Company for the Financial year ended March 31, 2023 along with Report of the Auditors thereon. |
| 14-JUL-2023 | Postal Ballot | Appointment of Mr. Vijay Nautamlal Bhatt (DIN: 00751001) as an Independent Director of the Company. |
| 22-SEP-2022 | AGM | To consider and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended March 31, 2022 together with the Reports of the Board of Directors and Auditors thereon. |
| 22-SEP-2022 | AGM | To re-appoint existing Statutory Auditors i.e. M/s. BSR & Co. LLP for a further period of 5 (Five) years. |
| 22-SEP-2022 | AGM | To re-appoint Ms. Nomita R. Chandavarkar (DIN:00042332) as a Director, who retires by rotation and being eligible, offered herself for re-appointment. |
| 22-SEP-2022 | AGM | To consider and adopt the Audited Consolidated Financial Statement of the Company for the Financial Year ended March 31, 2022 along with Report of the Auditors thereon. |
FAQs on FDC Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.